The Role of Interstitial Brachytherapy for Breast Cancer Treatment: An Overview of Indications, Applications, and Technical Notes.

APBI accelerated partial breast irradiation brachytherapy brachytherapy boost breast cancer breast reirradiation breast salvage treatment ipsilateral breast recurrence muticatheter interstitial brachytherapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 May 2022
Historique:
received: 30 04 2022
revised: 19 05 2022
accepted: 20 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Breast cancer represents the second leading cause of cancer-related death in the female population, despite continuing advances in treatment options that have significantly accelerated in recent years. Conservative treatments have radically changed the concept of healing, also focusing on the psychological aspect of oncological treatments. In this scenario, radiotherapy plays a key role. Brachytherapy is an extremely versatile radiation technique that can be used in various settings for breast cancer treatment. Although it is invasive, technically complex, and requires a long learning curve, the dosimetric advantages and sparing of organs at risk are unequivocal. Literature data support muticatheter interstitial brachytherapy as the only method with strong scientific evidence to perform partial breast irradiation and reirradiation after previous conservative surgery and external beam radiotherapy, with longer follow-up than new, emerging radiation techniques, whose effectiveness is proven by over 20 years of experience. The aim of our work is to provide a comprehensive view of the use of interstitial brachytherapy to perform breast lumpectomy boost, breast-conserving accelerated partial breast irradiation, and salvage reirradiation for ipsilateral breast recurrence, with particular focus on the implant description, limits, and advantages of the technique.

Identifiants

pubmed: 35626168
pii: cancers14102564
doi: 10.3390/cancers14102564
pmc: PMC9139312
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):851-8
pubmed: 9531370
Radiother Oncol. 2004 Jul;72(1):25-33
pubmed: 15236871
N Engl J Med. 1985 Mar 14;312(11):665-73
pubmed: 3883167
Clin Transl Oncol. 2022 Jan;24(1):24-33
pubmed: 34213744
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1123-1128
pubmed: 33220220
Lancet Oncol. 2018 Jun;19(6):834-844
pubmed: 29695348
Lancet. 2016 Jan 16;387(10015):229-38
pubmed: 26494415
Lancet Oncol. 2017 Feb;18(2):259-268
pubmed: 28094198
Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):889-97
pubmed: 12095554
Breast. 2020 Aug;52:45-49
pubmed: 32380439
Radiother Oncol. 2013 Aug;108(2):197-202
pubmed: 23742961
Am J Clin Oncol. 2016 Oct;39(5):468-72
pubmed: 25822231
Breast Cancer Res Treat. 2019 Jul;176(1):149-157
pubmed: 30949798
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1385-92
pubmed: 15590169
Brachytherapy. 2018 Sep - Oct;17(5):825-830
pubmed: 29936130
Cancer Treat Rev. 2013 Nov;39(7):737-41
pubmed: 23465859
Eur J Surg Oncol. 2019 Aug;45(8):1317-1327
pubmed: 30795956
Radiother Oncol. 2016 Jan;118(1):199-204
pubmed: 26776444
Tumori. 2015 Mar-Apr;101(2):161-7
pubmed: 25768319
Ann Surg Oncol. 2013 Oct;20(10):3279-85
pubmed: 23975302
Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):998-1006
pubmed: 33186620
Brachytherapy. 2012 Sep-Oct;11(5):387-91
pubmed: 22104353
Lancet. 2019 Dec 14;394(10215):2155-2164
pubmed: 31813636
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1048-55
pubmed: 18359170
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1272-8
pubmed: 18495372
J Contemp Brachytherapy. 2019 Apr;11(2):108-115
pubmed: 31139218
Semin Surg Oncol. 1992 May-Jun;8(3):161-6
pubmed: 1496227
Brachytherapy. 2017 May - Jun;16(3):552-564
pubmed: 28377213
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1025-9
pubmed: 25442036
Radiother Oncol. 2007 Mar;82(3):281-6
pubmed: 17126940
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1239-46
pubmed: 14630257
Am J Clin Oncol. 1995 Aug;18(4):348-52
pubmed: 7625378
N Engl J Med. 2002 Oct 17;347(16):1233-41
pubmed: 12393820
Cancer Radiother. 2018 Jun;22(4):312-318
pubmed: 29858137
Radiother Oncol. 2010 Mar;94(3):264-73
pubmed: 20181402
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):531-6
pubmed: 19775830
Radiother Oncol. 2010 Mar;94(3):274-9
pubmed: 20181401
Brachytherapy. 2018 Nov - Dec;17(6):949-955
pubmed: 30227977
Breast. 2015 Dec;24(6):739-44
pubmed: 26459227
J Contemp Brachytherapy. 2021 Aug;13(4):387-394
pubmed: 34484352
Ann Surg Oncol. 2012 Nov;19(12):3771-6
pubmed: 22618719
Radiother Oncol. 2018 Sep;128(3):411-420
pubmed: 29691075
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1173-81
pubmed: 15519789
Radiother Oncol. 2013 Aug;108(2):226-31
pubmed: 23647758
N Engl J Med. 2001 Nov 8;345(19):1378-87
pubmed: 11794170
J Contemp Brachytherapy. 2020 Jun;12(3):207-215
pubmed: 32695191
Brachytherapy. 2019 May - Jun;18(3):411-419
pubmed: 30890318
Brachytherapy. 2021 Jan-Feb;20(1):163-170
pubmed: 32741559
Brachytherapy. 2020 Jan - Feb;19(1):90-96
pubmed: 31767533
J Natl Cancer Inst. 1992 May 6;84(9):683-9
pubmed: 1314910
Semin Radiat Oncol. 2005 Apr;15(2):116-22
pubmed: 15809937
Radiother Oncol. 2015 Jun;115(3):342-8
pubmed: 26104975
Rep Pract Oncol Radiother. 2010 Feb 18;15(1):1-7
pubmed: 24376915
Cancer. 1995 May 1;75(9):2328-36
pubmed: 7712444
Brachytherapy. 2021 May-Jun;20(3):631-637
pubmed: 33642174
J Natl Cancer Inst. 1994 May 4;86(9):717-22
pubmed: 8158702
Brachytherapy. 2018 Mar - Apr;17(2):407-414
pubmed: 29254856
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):17-24
pubmed: 20605365
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1460-1465
pubmed: 27479725
Brachytherapy. 2019 Mar - Apr;18(2):211-216
pubmed: 30554991
J Radiat Res. 2021 May 12;62(3):465-472
pubmed: 33604659
Radiother Oncol. 2009 Jan;90(1):48-55
pubmed: 18037181
Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):452-461
pubmed: 33383125
J Contemp Brachytherapy. 2019 Apr;11(2):101-107
pubmed: 31139217
J Contemp Brachytherapy. 2019 Aug;11(4):312-319
pubmed: 31523231
Jpn J Clin Oncol. 2020 Jul 9;50(7):743-752
pubmed: 32444872
Rep Pract Oncol Radiother. 2018 Nov-Dec;23(6):574-579
pubmed: 30534021
N Engl J Med. 1981 Jul 2;305(1):6-11
pubmed: 7015141
J Contemp Brachytherapy. 2018 Apr;10(2):97-104
pubmed: 29789758
Brachytherapy. 2011 May-Jun;10(3):171-7
pubmed: 20685178
Rep Pract Oncol Radiother. 2014 May 01;19(6):399-404
pubmed: 25337413
Ann Oncol. 2001 Jul;12(7):997-1003
pubmed: 11521809
CA Cancer J Clin. 2019 Sep;69(5):386-401
pubmed: 31361333
Brachytherapy. 2007 Oct-Dec;6(4):286-92
pubmed: 17991625
Brachytherapy. 2014 Jan-Feb;13(1):17-22
pubmed: 24041956
Brachytherapy. 2008 Jan-Mar;7(1):22-8
pubmed: 18299110
Strahlenther Onkol. 2006 Feb;182(2):102-7
pubmed: 16447017
Radiother Oncol. 2017 Jan;122(1):11-16
pubmed: 27474504
J Clin Oncol. 1999 Aug;17(8):2326-33
pubmed: 10561294
Brachytherapy. 2018 Jan - Feb;17(1):154-170
pubmed: 29074088
N Engl J Med. 2002 Oct 17;347(16):1227-32
pubmed: 12393819
Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):67-74
pubmed: 30611839
Ann Surg. 1937 Oct;106(4):619-30
pubmed: 17857063
Pract Radiat Oncol. 2017 Mar - Apr;7(2):73-79
pubmed: 27866865
Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):804-10
pubmed: 20106605
Radiother Oncol. 2012 Jan;102(1):96-101
pubmed: 21907439
Brachytherapy. 2021 Jul-Aug;20(4):807-817
pubmed: 33810984
Brachytherapy. 2019 Sep - Oct;18(5):627-634
pubmed: 31285131
Lancet Oncol. 2015 Jan;16(1):47-56
pubmed: 25500422

Auteurs

Salvatore Cozzi (S)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Matteo Augugliaro (M)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Patrizia Ciammella (P)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Andrea Botti (A)

Medical Physics Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Valeria Trojani (V)

Medical Physics Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Masoumeh Najafi (M)

Department of Radiation Oncology, Shohadaye Haft-e-Tir Hospital, Iran University of Medical Science, Teheran 1997667665, Iran.

Gladys Blandino (G)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Maria Paola Ruggieri (MP)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Lucia Giaccherini (L)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Emanuele Alì (E)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Federico Iori (F)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Angela Sardaro (A)

Interdisciplinary Department of Medicine, Section of Radiology and Radiation Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.

Sebastiano Finocchi Ghersi (S)

Radiation Oncolgy Unit, AOU Sant'Andrea, Facoltà di Medicina e Psicologia, Università La Sapienza, 00185 Rome, Italy.

Letizia Deantonio (L)

Radiation Oncology Clinic, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, 6500 Lugano, Switzerland.

Cristina Gutierrez Miguelez (C)

Brachytherapy Unit, Department of Radiation Oncology, Catalan Institute of Oncology, University of Barcelona, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

Cinzia Iotti (C)

Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

Lilia Bardoscia (L)

Radiation Oncology Unit, S. Luca Hospital, Healthcare Company Tuscany Nord Ovest, 55100 Lucca, Italy.

Classifications MeSH